|
ALBO
|
Albireo Pharma, Inc.
|
US
|
NASDAQ
|
|
BAX
|
Baxter International Inc.
|
US
|
NYSE
|
|
CBAY
|
CymaBay Therapeutics Inc.
|
US
|
NASDAQ
|
|
CGTX
|
Cognition Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CORT
|
Corcept Therapeutics Incorporated
|
US
|
NASDAQ
|
|
CPRX
|
Catalyst Pharmaceutical Partners, Inc.
|
US
|
NASDAQ
|
|
DXR
|
Daxor Corporation
|
US
|
NASDAQ
|
|
ELDN
|
Eledon Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ELYM
|
Eliem Therapeutics, Inc
|
US
|
NASDAQ
|
|
FULC
|
Fulcrum Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IBIO
|
iBio, Inc.
|
US
|
AMEX
|
|
IGC
|
India Globalization Capital Inc.
|
US
|
AMEX
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ISEE
|
IVERIC bio, Inc.
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
US
|
NASDAQ
|
|
KPRX
|
Kiora Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
KROS
|
Keros Therapeutics, Inc.
|
US
|
NASDAQ
|
|
LFST
|
LifeStance Health Group, Inc.
|
US
|
NASDAQ
|
|
MYMD
|
MyMD Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
US
|
NASDAQ
|